1. ScholarBank@NUS

Wee Joo Chng

rp04705

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
Main Affiliation
 
Faculty
 
Email
mdccwj@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Department:  OFFICE OF THE DEPUTY PRESIDENT(RES&TECH)
Type:  Review

Results 1-20 of 43 (Search time: 0.01 seconds).

Issue DateTitleAuthor(s)
123-Feb-2021Application of Advanced Mass Spectrometry-Based Proteomics to Study Hypoxia Driven Cancer ProgressionVinaiphat, Arada; Low, Jee Keem; Yeoh, Kheng Wei ; Chng, Wee Joo ; Sze, Siu Kwan
21-Mar-2022Biological Hallmarks and Emerging Strategies to Target STAT3 Signaling in Multiple MyelomaZhou, Jianbiao ; Chng, Wee-Joo 
329-Apr-2021CAR T-cell therapy in multiple myeloma: more room for improvementTeoh, Phaik Ju ; Chng, Wee Joo 
4Oct-2009Centrosomes and myeloma; aneuploidy and proliferationChng, W.J. ; Fonseca, R.
51-Nov-2019Comprehensive Analysis of ERK1/2 Substrates for Potential Combination ImmunotherapiesYang, Lei ; Zheng, Liangzhen; Chng, Wee Joo ; Ding, Jeak Ling 
618-Feb-2021Crosstalk between endoplasmic reticulum stress and oxidative stress: a dynamic duo in multiple myelomaXiong, Sinan; Chng, Wee-Joo ; Zhou, Jianbiao 
71-Mar-2021Daratumumab-based induction therapy for multiple myeloma: A systematic review and meta-analysisChong, Lip Leong; Soon, Yu Yang ; Soekojo, Cinnie Yentia; Ooi, Melissa ; Chng, Wee Joo ; de Mel, Sanjay
82020Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myelomaDimopoulos, M.A.; Jakubowiak, A.J.; McCarthy, P.L.; Orlowski, R.Z.; Attal, M.; Bladé, J.; Goldschmidt, H.; Weisel, K.C.; Ramasamy, K.; Zweegman, S.; Spencer, A.; Huang, J.S.Y.; Lu, J.; Sunami, K.; Iida, S.; Chng, W.-J. ; Holstein, S.A.; Rocci, A.; Skacel, T.; Labotka, R.; Palumbo, A.; Anderson, K.C.
92019EZH2 abnormalities in lymphoid malignancies: Underlying mechanisms and therapeutic implicationsLi, B. ; Chng, W.-J. 
1025-May-2022Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic ChallengesDa, Yi; Goh, Giap Hean; Lau, Titus; Chng, Wee Joo ; Soekojo, Cinnie Yentia
119-Jun-2022Immunoglobulin M Monoclonal Gammopathies of Clinical SignificanceGirard, Louis-Pierre; Soekojo, Cinnie Yentia; Ooi, Melissa; Chng, Wee Joo ; de Mel, Sanjay
122020Immunoglobulin m paraproteinaemiasGirard, L.-P.; Soekojo, C.Y.; Ooi, M.; Poon, L.M.; Chng, W.-J. ; de Mel, S.
131-Mar-2020Immunotherapy in Multiple MyelomaSoekojo, Cinnie Yentia; Ooi, Melissa ; de Mel, Sanjay; Chng, Wee Joo 
142014Implications of heterogeneity in multiple myelomaDe Mel S.; Lim S.H.; Tung M.L.; Chng W.-J. 
15Feb-2014IMWG consensus on risk stratification in multiple myelomaChng, W.J. ; Dispenzieri, A.; Chim, C.-S.; Fonseca, R.; Goldschmidt, H.; Lentzsch, S.; Munshi, N.; Palumbo, A.; Miguel, J.S.; Sonneveld, P.; Cavo, M.; Usmani, S.; Durie, B.G.; Avet-Loiseau, H.
161-Oct-2021Janus Kinase Signaling: Oncogenic Criminal of Lymphoid CancersLi, Boheng; Wan, Qin; Li, Zhubo; Chng, Wee-Joo 
17Nov-2013Management of multiple myeloma in asia: Resource-stratified guidelinesTan, D.; Chng, W.J. ; Chou, T.; Nawarawong, W.; Hwang, S.-Y.; Chim, C.S.; Chen, W.; Durie, B.G.M.; Lee, J.H.
18Apr-2012Management of treatment-emergent peripheral neuropathy in multiple myelomaRichardson, P.G.; Delforge, M.; Beksac, M.; Wen, P.; Jongen, J.L.; Sezer, O.; Terpos, E.; Munshi, N.; Palumbo, A.; Rajkumar, S.V.; Harousseau, J.L.; Moreau, P.; Avet-Loiseau, H.; Lee, J.H.; Cavo, M.; Merlini, G.; Voorhees, P.; Chng, W.J. ; Mazumder, A.; Usmani, S.; Einsele, H.; Comenzo, R.; Orlowski, R.; Vesole, D.; Lahuerta, J.J.; Niesvizky, R.; Siegel, D.; Mateos, M.-V.; Dimopoulos, M.; Lonial, S.; Jagannath, S.; Bladé, J.; Miguel, J.S.; Morgan, G.; Anderson, K.C.; Durie, B.G.M.; Sonneveld, P.
191-Apr-2022Metabolic Vulnerabilities in Multiple MyelomaLim, Julia SL ; Chong, Phyllis SY ; Chng, Wee-Joo 
202014MicroRNA: Important player in the pathobiology of multiple myelomaBi C.; Chng W.J.